Colgate-Palmolive is a Dividend King with a 62-year record of dividend growth and global dominance in oral care products. CL recently rebounded from a multi-year earnings decline, driven by its 2022 ...

In times of geopolitical strain and volatile commodity prices, investors often gravitate towards companies with resilient, time-tested business models. Colgate- ...

During the last three months, 15 analysts shared their evaluations of Colgate-Palmolive (NYSE:CL), revealing diverse outlooks from bullish to bearish. The following table summarizes their recent ...

Providing a diverse range of perspectives from bullish to bearish, 17 analysts have published ratings on Colgate-Palmolive (NYSE:CL) in the last three months. The table below provides a snapshot of ...

If you are wondering whether Colgate-Palmolive is fairly priced or if the current tag leaves some value on the table, you will want to look past the brand name and into what the numbers are really ...

Perspective is essential when investing. For example, market participants who are scoping out consumer packaged goods stocks as potential rebound opportunities for 2026 may be on to something, because ...

Colgate-Palmolive’s next dividend hike: forecast 2.9–4.8% after restructuring-driven growth. Read here for a detailed investment analysis.

Colgate-Palmolive (CL) is back in focus after rolling out its 2030 Strategic Plan. The roadmap is centered on brand strength, science driven product development, and sharper omnichannel execution that ...

Colgate-Palmolive and Emerson Electric are both financially solid businesses to invest in. One company offers a higher dividend yield, but the other has more share-price momentum. Follow 24/7 Wall St.

We think that Colgate-Palmolive stock (NYSE: CL) is currently a better pick over its industry peer – Kimberly-Clark stock (NYSE: KMB). CL stock trades at 3.5x trailing revenues, versus 2.1x for KMB.